Parkinson's disease is the world's fastest-growing neurological disorder. Research to elucidate the mechanisms of Parkinson's disease and automate diagnostics would greatly improve the treatment of patients with Parkinson's disease. Current diagnostic methods are expensive and have limited availability. Considering the insidious and preclinical onset and progression of the disease, a desirable screening should be diagnostically accurate even before the onset of symptoms to allow medical interventions. We highlight retinal fundus imaging, often termed a window to the brain, as a diagnostic screening modality for Parkinson's disease. We conducted a systematic evaluation of conventional machine learning and deep learning techniques to classify Parkinson's disease from UK Biobank fundus imaging. Our results show that Parkinson's disease individuals can be differentiated from age and gender-matched healthy subjects with an Area Under the Curve (AUC) of 0.77. This accuracy is maintained when predicting either prevalent or incident Parkinson's disease. Explainability and trustworthiness are enhanced by visual attribution maps of localized biomarkers and quantified metrics of model robustn
Parkinson's disease (PD) is a neurodegenerative condition characterized by notable motor and non-motor manifestations. The assessment tool known as the Unified Parkinson's Disease Rating Scale (UPDRS) plays a crucial role in evaluating the extent of symptomatology associated with Parkinson's Disease (PD). This research presents a complete approach for predicting UPDRS scores using sophisticated Long Short-Term Memory (LSTM) networks that are improved using attention mechanisms, data augmentation techniques, and robust feature selection. The data utilized in this work was obtained from the UC Irvine Machine Learning repository. It encompasses a range of speech metrics collected from patients in the early stages of Parkinson's disease. Recursive Feature Elimination (RFE) was utilized to achieve efficient feature selection, while the application of jittering enhanced the dataset. The Long Short-Term Memory (LSTM) network was carefully crafted to capture temporal fluctuations within the dataset effectively. Additionally, it was enhanced by integrating an attention mechanism, which enhances the network's ability to recognize sequence importance. The methodology that has been described p
Deep learning holds tremendous potential in healthcare for uncovering hidden patterns within extensive clinical datasets, aiding in the diagnosis of various diseases. Parkinson's disease (PD) is a neurodegenerative condition characterized by the deterioration of brain function. In the initial stages of PD, automatic diagnosis poses a challenge due to the similarity in behavior between individuals with PD and those who are healthy. Our objective is to propose an effective model that can aid in the early detection of Parkinson's disease. We employed the VGRF gait signal dataset sourced from Physionet for distinguishing between healthy individuals and those diagnosed with Parkinson's disease. This paper introduces a novel deep learning architecture based on the LSTM network for automatically detecting freezing of gait episodes in Parkinson's disease patients. In contrast to conventional machine learning algorithms, this method eliminates manual feature engineering and proficiently captures prolonged temporal dependencies in gait patterns, thereby improving the diagnosis of Parkinson's disease. The LSTM network resolves the issue of vanishing gradients by employing memory blocks in pla
Parkinson's disease is easy to diagnose when it is advanced, but it is very difficult to diagnose in its early stages. Early diagnosis is essential to be able to treat the symptoms. It impacts on daily activities and reduces the quality of life of both the patients and their families and it is also the second most prevalent neurodegenerative disorder after Alzheimer in people over the age of 60. Most current studies on the prediction of Parkinson's severity are carried out in advanced stages of the disease. In this work, the study analyzes a set of variables that can be easily extracted from voice analysis, making it a very non-intrusive technique. In this paper, a method based on different deep learning techniques is proposed with two purposes. On the one hand, to find out if a person has severe or non-severe Parkinson's disease, and on the other hand, to determine by means of regression techniques the degree of evolution of the disease in a given patient. The UPDRS (Unified Parkinson's Disease Rating Scale) has been used by taking into account both the motor and total labels, and the best results have been obtained using a mixed multi-layer perceptron (MLP) that classifies and re
Parkinson's disease is a neurological condition that occurs in nearly 1% of the world's population. The disease is manifested by a drop in dopamine production, symptoms are cognitive and behavioural and include a wide range of personality changes, depressive disorders, memory problems, and emotional dysregulation, which can occur as the disease progresses. Early diagnosis and accurate staging of the disease are essential to apply the appropriate therapeutic approaches to slow cognitive and motor decline. Currently, there is not a single blood test or biomarker available to diagnose Parkinson's disease. Magnetic resonance imaging has been used for the past three decades to diagnose and distinguish between PD and other neurological conditions. However, in recent years new possibilities have arisen: several AI algorithms have been developed to increase the precision and accuracy of differential diagnosis of PD at an early stage. To our knowledge, no AI tools have been designed to identify the stage of progression. This paper aims to fill this gap. Using the "Parkinson's Progression Markers Initiative" dataset, which reports the patient's MRI and an indication of the disease stage, we
Parkinson's disease is a progressive neurodegenerative disorder affecting motor and non-motor functions, with speech impairments among its earliest symptoms. Speech impairments offer a valuable diagnostic opportunity, with machine learning advances providing promising tools for timely detection. In this research, we propose a deep learning approach for early Parkinson's disease detection from speech recordings, which also highlights the vocal segments driving predictions to enhance interpretability. This approach seeks to associate predictive speech patterns with articulatory features, providing a basis for interpreting underlying neuromuscular impairments. We evaluated our approach using the Italian Parkinson's Voice and Speech Database, containing 831 audio recordings from 65 participants, including both healthy individuals and patients. Our approach showed competitive classification performance compared to state-of-the-art methods, while providing enhanced interpretability by identifying key speech features influencing predictions.
Parkinson's disease (PD) is one of the major public health problems in the world. It is a well-known fact that around one million people suffer from Parkinson's disease in the United States whereas the number of people suffering from Parkinson's disease worldwide is around 5 million. Thus, it is important to predict Parkinson's disease in early stages so that early plan for the necessary treatment can be made. People are mostly familiar with the motor symptoms of Parkinson's disease, however, an increasing amount of research is being done to predict the Parkinson's disease from non-motor symptoms that precede the motor ones. If an early and reliable prediction is possible then a patient can get a proper treatment at the right time. Nonmotor symptoms considered are Rapid Eye Movement (REM) sleep Behaviour Disorder (RBD) and olfactory loss. Developing machine learning models that can help us in predicting the disease can play a vital role in early prediction. In this paper, we extend a work which used the non-motor features such as RBD and olfactory loss. Along with this the extended work also uses important biomarkers. In this paper, we try to model this classifier using different m
Parkinson's disease (PD) is a neurodegenerative disease affecting about 1% of people over the age of 60, causing motor impairments that impede hand coordination activities such as writing and drawing. Many approaches have tried to support early detection of Parkinson's disease based on hand-drawn images; however, we identified two major limitations in the related works: (1) the lack of sufficient datasets, (2) the robustness when dealing with unseen patient data. In this paper, we propose a new approach to detect Parkinson's disease that consists of two stages: The first stage classifies based on their drawing type(circle, meander, spiral), and the second stage extracts the required features from the images and detects Parkinson's disease. We overcame the previous two limitations by applying a chunking strategy where we divide each image into 2x2 chunks. Each chunk is processed separately when extracting features and recognizing Parkinson's disease indicators. To make the final classification, an ensemble method is used to merge the decisions made from each chunk. Our evaluation shows that our proposed approach outperforms the top performing state-of-the-art approaches, in particul
One of the most catastrophic neurological disorders worldwide is Parkinson's Disease. Along with it, the treatment is complicated and abundantly expensive. The only effective action to control the progression is diagnosing it in the early stage. However, this is challenging because early detection necessitates a large and complex clinical study. This experimental work used Machine Learning techniques to automate the early detection of Parkinson's Disease from clinical characteristics, voice features and motor examination. In this study, we develop ML models utilizing a public dataset of 130 individuals, 30 of whom are untreated Parkinson's Disease patients, 50 of whom are Rapid Eye Movement Sleep Behaviour Disorder patients who are at a greater risk of contracting Parkinson's Disease, and 50 of whom are Healthy Controls. We use MinMax Scaler to rescale the data points, Local Outlier Factor to remove outliers, and SMOTE to balance existing class frequency. Afterwards, apply a number of Machine Learning techniques. We implement the approaches in such a way that data leaking and overfitting are not possible. Finally, obtained 100% accuracy in classifying PD and RBD patients, as well a
Parkinson's disease is a widespread neurodegenerative condition necessitating early diagnosis for effective intervention. This paper introduces an innovative method for diagnosing Parkinson's disease through the analysis of human EEG signals, employing a Support Vector Machine (SVM) classification model. this research presents novel contributions to enhance diagnostic accuracy and reliability. Our approach incorporates a comprehensive review of EEG signal analysis techniques and machine learning methods. Drawing from recent studies, we have engineered an advanced SVM-based model optimized for Parkinson's disease diagnosis. Utilizing cutting-edge feature engineering, extensive hyperparameter tuning, and kernel selection, our method achieves not only heightened diagnostic accuracy but also emphasizes model interpretability, catering to both clinicians and researchers. Moreover, ethical concerns in healthcare machine learning, such as data privacy and biases, are conscientiously addressed. We assess our method's performance through experiments on a diverse dataset comprising EEG recordings from Parkinson's disease patients and healthy controls, demonstrating significantly improved dia
Parkinson's disease is a progressive and slowly developing neurodegenerative disease, characterized by dopaminergic neuron loss in the substantia nigra region of the brain. Despite extensive research by scientists, there is not yet a cure to this problem and the available therapies mainly help to reduce some of the Parkinson's symptoms. Drug repurposing (that is, the process of finding new uses for existing drugs) receives more appraisals as an efficient way that allows for reducing the time, resources, and risks associated with the development of new drugs. In this research, we design a novel computational platform that integrates gene expression data, biological networks, and the PDOD database to identify possible drug-repositioning agents for PD therapy. By using machine learning approaches like the RWR algorithm and PDOD scoring system we arrange drug-disease conversions and sort our potential sandboxes according to their possible efficacy. We propose gene expression analysis, network prioritization, and drug target data analysis to arrive at a comprehensive evaluation of drug repurposing chances. Our study results highlight such therapies as promising drug candidates to conduc
Parkinson's disease is a neurodegenerative disease that can affect a person's movement, speech, dexterity, and cognition. Clinicians primarily diagnose Parkinson's disease by performing a clinical assessment of symptoms. However, misdiagnoses are common. One factor that contributes to misdiagnoses is that the symptoms of Parkinson's disease may not be prominent at the time the clinical assessment is performed. Here, we present a machine-learning approach towards distinguishing between people with and without Parkinson's disease using long-term data from smartphone-based walking, voice, tapping and memory tests. We demonstrate that our attentive deep-learning models achieve significant improvements in predictive performance over strong baselines (area under the receiver operating characteristic curve = 0.85) in data from a cohort of 1853 participants. We also show that our models identify meaningful features in the input data. Our results confirm that smartphone data collected over extended periods of time could in the future potentially be used as a digital biomarker for the diagnosis of Parkinson's disease.
Background and objectives: Parkinson's disease is a neurological disorder that affects the motor system producing lack of coordination, resting tremor, and rigidity. Impairments in handwriting are among the main symptoms of the disease. Handwriting analysis can help in supporting the diagnosis and in monitoring the progress of the disease. This paper aims to evaluate the importance of different groups of features to model handwriting deficits that appear due to Parkinson's disease; and how those features are able to discriminate between Parkinson's disease patients and healthy subjects. Methods: Features based on kinematic, geometrical and non-linear dynamics analyses were evaluated to classify Parkinson's disease and healthy subjects. Classifiers based on K-nearest neighbors, support vector machines, and random forest were considered. Results: Accuracies of up to $93.1\%$ were obtained in the classification of patients and healthy control subjects. A relevance analysis of the features indicated that those related to speed, acceleration, and pressure are the most discriminant. The automatic classification of patients in different stages of the disease shows $κ$ indexes between $0.3
Liu et al. recently reported that biallelic mutations in DAGLB are responsible for autosomal recessive early-onset Parkinson's disease. They identified six patients carrying DAGLB mutations, all of Chinese origin and presenting with typical Parkinson disease. No additional cases outside China have been reported so far.To assess the causality of DAGLB in our cohort, we used data mining in the exomes of 684 index cases with either autosomal recessive or sporadic early onset Parkinson disease (< 50 years). We identified a homozygous p.Pro357Leu missense variant in a single consanguineous PD case. This mutation predicted deleterious, affects a conserved amino acid localized in the catalytic domain of the protein nearby the pathological p.Asp363Gly mutation described in the previous paper. As the most frequent genes involved in AR-PD (PRKN, PINK1), the DAGLB-associated disease presents and evolves like typical PD.This work reinforces the fact that DAGLB is involved in early onset Parkinson disease, but given the fact that we identified a single patient among 684 index cases screened, we conclude that DAGLB is a very rare cause of early onset autosomal recessive Parkinson disease. How
Hypomimia is a non-motor symptom of Parkinson's disease that manifests as delayed facial movements and expressions, along with challenges in articulation and emotion. Currently, subjective evaluation by neurologists is the primary method for hypomimia detection, and conventional rehabilitation approaches heavily rely on verbal prompts from rehabilitation physicians. There remains a deficiency in accessible, user-friendly and scientifically rigorous assistive tools for hypomimia treatments. To investigate this, we developed HypomimaCoach, an Action Unit (AU)-based digital therapy system for hypomimia detection and rehabilitation in Parkinson's disease. The HypomimaCoach system was designed to facilitate engagement through the incorporation of both relaxed and controlled rehabilitation exercises, while also stimulating initiative through the integration of digital therapies that incorporated traditional face training methods. We extract action unit(AU) features and their relationship for hypomimia detection. In order to facilitate rehabilitation, a series of training programmes have been devised based on the Action Units (AUs) and patients are provided with real-time feedback through
Parkinson's Disease afflicts millions of individuals globally. Emerging as a promising brain rehabilitation therapy for Parkinson's Disease, Closed-loop Deep Brain Stimulation (CL-DBS) aims to alleviate motor symptoms. The CL-DBS system comprises an implanted battery-powered medical device in the chest that sends stimulation signals to the brains of patients. These electrical stimulation signals are delivered to targeted brain regions via electrodes, with the magnitude of stimuli adjustable. However, current CL-DBS systems utilize energy-inefficient approaches, including reinforcement learning, fuzzy interface, and field-programmable gate array (FPGA), among others. These approaches make the traditional CL-DBS system impractical for implanted and wearable medical devices. This research proposes a novel neuromorphic approach that builds upon Leaky Integrate and Fire neuron (LIF) controllers to adjust the magnitude of DBS electric signals according to the various severities of PD patients. Our neuromorphic controllers, on-off LIF controller, and dual LIF controller, successfully reduced the power consumption of CL-DBS systems by 19% and 56%, respectively. Meanwhile, the suppression e
Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common neurodegenerative disorders in humans. Because a significant percentage of patients have clinical and pathological features of both diseases, it has been hypothesized that the patho-cascades of the two diseases overlap. Despite this evidence, these two diseases are rarely studied in a joint manner. In this paper, we utilize clinical, imaging, genetic, and biospecimen features to cluster AD and PD patients into the same feature space. By training a machine learning classifier on the combined feature space, we predict the disease stage of patients two years after their baseline visits. We observed a considerable improvement in the prediction accuracy of Parkinson's dementia patients due to combined training on Alzheimer's and Parkinson's patients, thereby affirming the claim that these two diseases can be jointly studied.
Modelling the progression of Degenerative Diseases (DD) is essential for detection, prevention, and treatment, yet it remains challenging due to the heterogeneity in disease trajectories among individuals. Factors such as demographics, genetic conditions, and lifestyle contribute to diverse phenotypical manifestations, necessitating patient stratification based on these variations. Recent methods like Subtype and Stage Inference (SuStaIn) have advanced unsupervised stratification of disease trajectories, but they face potential limitations in robustness, interpretability, and temporal granularity. To address these challenges, we introduce Disease Progression Modelling and Stratification (DP-MoSt), a novel probabilistic method that optimises clusters of continuous trajectories over a long-term disease time-axis while estimating the confidence of trajectory sub-types for each biomarker. We validate DP-MoSt using both synthetic and real-world data from the Parkinson's Progression Markers Initiative (PPMI). Our results demonstrate that DP-MoSt effectively identifies both sub-trajectories and subpopulations, and is a promising alternative to current state-of-the-art models.
At present, the vast majority of human subjects with neurological disease are still diagnosed through in-person assessments and qualitative analysis of patient data. In this paper, we propose to use Topological Data Analysis (TDA) together with machine learning tools to automate the process of Parkinson's disease classification and severity assessment. An automated, stable, and accurate method to evaluate Parkinson's would be significant in streamlining diagnoses of patients and providing families more time for corrective measures. We propose a methodology which incorporates TDA into analyzing Parkinson's disease postural shifts data through the representation of persistence images. Studying the topology of a system has proven to be invariant to small changes in data and has been shown to perform well in discrimination tasks. The contributions of the paper are twofold. We propose a method to 1) classify healthy patients from those afflicted by disease and 2) diagnose the severity of disease. We explore the use of the proposed method in an application involving a Parkinson's disease dataset comprised of healthy-elderly, healthy-young and Parkinson's disease patients. Our code is ava
Detecting Parkinson's Disease in its early stages using EEG data presents a significant challenge. This paper introduces a novel approach, representing EEG data as a 15-variate series of bandpower and peak frequency values/coefficients. The hypothesis is that this representation captures essential information from the noisy EEG signal, improving disease detection. Statistical features extracted from this representation are utilised as input for interpretable machine learning models, specifically Decision Tree and AdaBoost classifiers. Our classification pipeline is deployed within our proposed framework which enables high-importance data types and brain regions for classification to be identified. Interestingly, our analysis reveals that while there is no significant regional importance, the N1 sleep data type exhibits statistically significant predictive power (p < 0.01) for early-stage Parkinson's Disease classification. AdaBoost classifiers trained on the N1 data type consistently outperform baseline models, achieving over 80% accuracy and recall. Our classification pipeline statistically significantly outperforms baseline models indicating that the model has acquired useful